Please use this identifier to cite or link to this item:
Title: Proteasome inhibitor-induced coronary vasospasm in multiple myeloma: A case report
Authors: Rogers, James ;Forsyth, Cecily J ;Ford, Tom ;Mikhail, Philopatir 
Affliation: Central Coast Local Health District
Gosford Hospital
The University of Newcastle
Issue Date: Jul-2021
Source: 5(7):ytab076
Journal title: European heart journal. Case reports
Department: Cardiology
Abstract: BACKGROUND: Coronary vasospasm is an increasingly recognized cause of myocardial infarction or myocardial ischaemia in patients without obstructive coronary artery disease. A thorough medication review may identify drugs or toxins that could trigger coronary vasospasm. This case provides mechanistic insight into the off-target effect of proteasome inhibition leading to coronary vasospasm in a patient referred with chest pain consistent with typical angina. CASE SUMMARY: A 72-year-old lady presented with anginal chest pain at rest with electrocardiogram evidence of myocardial ischaemia who was referred for invasive coronary angiography. This demonstrated minor coronary disease without an obstructive lesion. Vasoreactivity testing revealed diffuse coronary vasospasm of the left anterior descending artery. Carfilzomib was identified as the trigger for coronary vasospasm. Symptoms resolved without recurrence after appropriate treatment including cessation of the triggering agent. CONCLUSION: Coronary spasm is a rare but important adverse reaction to proteasome inhibitors. This case supports the clinical utility of invasive coronary vasoreactivity testing in patients with ischaemia with no obstructive coronary artery disease.
DOI: 10.1093/ehjcr/ytab076
ISSN: 2514-2119
Publicaton type: Journal Article
Keywords: Cardiology
Study or Trial: Case Series and Case Reports
Appears in Collections:Cardiology

Show full item record

Page view(s)

checked on Jun 4, 2023

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.